Reddy’s as it is better known - Dr. Reddy’s Laboratories Ltd was established during 1984 by Dr. Anji Reddy and gradually became the largest pharmaceutical company of India by now. Reddy enjoys the healthy work experience through his earlier service with Indian Drugs & Pharmaceuticals Ltd – IDPL. The company is now producing and marketing the array of pharmaceutical formulations both in Indian and International markets. The company today owns over 190 different medication products under prescription category, 60 active pharmaceutical ingredients-APIs or raw materials required by the drug manufacturers, diagnostic kits for various applications, critical care as well as biotechnology products. 

 

The company’s main motto is enabling people to direct improved and healthy lives through a couple of analogous intentions like providing economic and easy to get to medications in all corners of the world as well as developing and marketing advanced medications to fulfill the medical necessities. Reddy’s is upright consolidated pharmaceutical enterprise having its existence in over 100 nations of the world and is one of the foremost world-wide generic pharmaceutical enterprises by revenues. The strong business stature of Reddy’s, characteristics and products strengthens the company with the calculated advantages of vertical assimilation that permits it to outrival in the more and more competitive markets world-wide.

 

The products portfolios of Reddy’s mention like:

 

Major Pharmaceutical brands like: OMEZ, NISE, STALMO, STALMO-BETA, ENAM, ATOCOR, RAZO, RECLIMET, CLAMP and MINTOP.

 

The major Active Pharmaceutical Ingredients-APIs like: Ciprofloxacin Hydrochloride, Ramipril, Terbinafine Hydrochloride, Ibuprofen, Sertraline Hydrochloride, Ranitidine Hydrochloride Form-2, Naproxen Sodium, Naproxen, Atorvastatin, Montelukast, Losartan Potassium, Sparfloxacin, Nizatidine, Ranitidine Hydrochloride Form-1 and Clopidogrel.